Northeast Financial Consultants’s Invesco Pharmaceuticals ETF PJP Stock Holding History

Northeast Financial Consultants’s Portfolio PJP Stock Details PJP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-3,135	Closed	-$243K	–	367
2021 Q3	$243K	Sell	3,135 -494	-14%	-$39.8K	0.02%	306
2021 Q2	$292K	Sell	3,629 -4,420	-55%	-$351K	0.02%	289
2021 Q1	$635K	Buy	8,049 +7	+0.1%	+$546	0.05%	180
2020 Q4	$574K	Sell	8,042 -775	-9%	-$51.9K	0.05%	183
2020 Q3	$563K	Sell	8,817 -4	-0%	-$261	0.05%	165
2020 Q2	$571K	Buy	+8,821	New	+$548K	0.05%	157
2018 Q1	–	Sell	-3,300	Closed	-$211K	–	155
2017 Q4	$211K	Sell	3,300 -325	-9%	-$20.8K	0.07%	139
2017 Q3	$237K	Sell	3,625 -5,650	-61%	-$357K	0.09%	132
2017 Q2	$582K	Sell	9,275 -3,150	-25%	-$189K	0.23%	81
2017 Q1	$730K	Sell	12,425 -17,550	-59%	-$1.03M	0.3%	61
2016 Q4	$1.68M	Sell	29,975 -60,340	-67%	-$3.48M	0.75%	25
2016 Q3	$5.55M	Sell	90,315 -50,105	-36%	-$3.28M	2.35%	7
2016 Q2	$8.91M	Sell	140,420 -4,554	-3%	-$286K	3.96%	3
2016 Q1	$8.71M	Sell	144,974 -4,959	-3%	-$303K	4.57%	2
2015 Q4	$10.5M	Buy	149,933 +4,729	+3%	+$335K	5.44%	2
2015 Q3	$9.63M	Buy	145,204 +20,655	+17%	+$1.61M	4.89%	2
2015 Q2	$9.76M	Buy	124,549 +10,361	+9%	+$807K	4.37%	2
2015 Q1	$8.72M	Buy	114,188 +49,361	+76%	+$3.63M	3.97%	3
2014 Q4	$4.31M	Buy	64,827 +12,852	+25%	+$856K	2.27%	9
2014 Q3	$3.31M	Buy	51,975 +5,863	+13%	+$362K	1.82%	12
2014 Q2	$2.82M	Buy	46,112 +8,625	+23%	+$500K	1.59%	13
2014 Q1	$2.12M	Buy	37,487 +23,285	+164%	+$1.32M	1.25%	17
2013 Q4	$760K	Buy	+14,202	New	+$711K	0.51%	38

Other funds holding PJP

PAM

Peak Asset Management Louisville, Colorado $680M AUM 22.27% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

FDCDDQ

Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $32.7B AUM 35.71% 1-Year Est. Return

USCWA

U.S. Capital Wealth Advisors Austin, Texas $3.98B AUM 22.36% 1-Year Est. Return

DBIA

Dumont & Blake Investment Advisors Princeton, New Jersey $445M AUM 31.98% 1-Year Est. Return

Northeast Financial Consultants's PJP Position: Q4 2021 in Review

Northeast Financial Consultants sold out of Invesco Pharmaceuticals ETF (PJP) in Q4 2021, closing a stake of 3,135 shares — an estimated $243K sold.

Northeast Financial Consultants first reported a position in PJP in Q4 2013 and held it in 23 quarters. The position peaked at $10.5M in Q4 2015. 82 funds tracked by Wall St. Rank hold PJP as of Q4 2021.

Northeast Financial Consultants reported no remaining Invesco Pharmaceuticals ETF position as of Q4 2021 after selling out during the quarter.
Northeast Financial Consultants sold 3,135 Invesco Pharmaceuticals ETF shares in Q4 2021, an estimated $243K.
Northeast Financial Consultants first reported a position in Invesco Pharmaceuticals ETF in Q4 2013 and held it in 23 quarters.
Northeast Financial Consultants's Invesco Pharmaceuticals ETF position peaked at $10.5M in Q4 2015.
82 funds tracked by Wall St. Rank held Invesco Pharmaceuticals ETF as of Q4 2021.

Based on Northeast Financial Consultants's 13F filing for Q4 2021, filed 11 Feb 2022.